ALZECURE PHARMA's market value is the price at which a share of ALZECURE PHARMA trades on a public exchange. It measures the collective expectations of ALZECURE PHARMA AB investors about its performance. ALZECURE PHARMA is trading at 0.24 as of the 3rd of August 2025. This is a 17.24 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.24. With this module, you can estimate the performance of a buy and hold strategy of ALZECURE PHARMA AB and determine expected loss or profit from investing in ALZECURE PHARMA over a given investment horizon. Check out ALZECURE PHARMA Correlation, ALZECURE PHARMA Volatility and ALZECURE PHARMA Alpha and Beta module to complement your research on ALZECURE PHARMA.
Please note, there is a significant difference between ALZECURE PHARMA's value and its price as these two are different measures arrived at by different means. Investors typically determine if ALZECURE PHARMA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ALZECURE PHARMA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ALZECURE PHARMA 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ALZECURE PHARMA's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ALZECURE PHARMA.
0.00
05/05/2025
No Change 0.00
0.0
In 3 months and 1 day
08/03/2025
0.00
If you would invest 0.00 in ALZECURE PHARMA on May 5, 2025 and sell it all today you would earn a total of 0.00 from holding ALZECURE PHARMA AB or generate 0.0% return on investment in ALZECURE PHARMA over 90 days. ALZECURE PHARMA is related to or competes with SEALED AIR, G III, Enter Air, Alaska Air, SWISS WATER, Luckin Coffee, and Corsair Gaming. AlzeCure Pharma AB , a pharmaceutical company, develops drug therapies for the treatment of Alzheimers and Parkinsons di... More
ALZECURE PHARMA Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ALZECURE PHARMA's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ALZECURE PHARMA AB upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for ALZECURE PHARMA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ALZECURE PHARMA's standard deviation. In reality, there are many statistical measures that can use ALZECURE PHARMA historical prices to predict the future ALZECURE PHARMA's volatility.
ALZECURE PHARMA is out of control given 3 months investment horizon. ALZECURE PHARMA AB secures Sharpe Ratio (or Efficiency) of 0.0919, which signifies that the company had a 0.0919 % return per unit of volatility over the last 3 months. We were able to interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.39% are justified by taking the suggested risk. Use ALZECURE PHARMA mean deviation of 11.26, and Risk Adjusted Performance of 0.0904 to evaluate company specific risk that cannot be diversified away. ALZECURE PHARMA holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.97, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning ALZECURE PHARMA are expected to decrease slowly. On the other hand, during market turmoil, ALZECURE PHARMA is expected to outperform it slightly. Use ALZECURE PHARMA value at risk, downside variance, and the relationship between the maximum drawdown and potential upside , to analyze future returns on ALZECURE PHARMA.
Auto-correlation
0.46
Average predictability
ALZECURE PHARMA AB has average predictability. Overlapping area represents the amount of predictability between ALZECURE PHARMA time series from 5th of May 2025 to 19th of June 2025 and 19th of June 2025 to 3rd of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ALZECURE PHARMA AB price movement. The serial correlation of 0.46 indicates that about 46.0% of current ALZECURE PHARMA price fluctuation can be explain by its past prices.
Correlation Coefficient
0.46
Spearman Rank Test
0.31
Residual Average
0.0
Price Variance
0.0
ALZECURE PHARMA AB lagged returns against current returns
Autocorrelation, which is ALZECURE PHARMA stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ALZECURE PHARMA's stock expected returns. We can calculate the autocorrelation of ALZECURE PHARMA returns to help us make a trade decision. For example, suppose you find that ALZECURE PHARMA has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
ALZECURE PHARMA regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ALZECURE PHARMA stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ALZECURE PHARMA stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ALZECURE PHARMA stock over time.
Current vs Lagged Prices
Timeline
ALZECURE PHARMA Lagged Returns
When evaluating ALZECURE PHARMA's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ALZECURE PHARMA stock have on its future price. ALZECURE PHARMA autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ALZECURE PHARMA autocorrelation shows the relationship between ALZECURE PHARMA stock current value and its past values and can show if there is a momentum factor associated with investing in ALZECURE PHARMA AB.
ALZECURE PHARMA financial ratios help investors to determine whether ALZECURE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALZECURE with respect to the benefits of owning ALZECURE PHARMA security.